Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical ANTIBODY CXD101 500ug
SDP

Catalog No. 502983908
Encompass_Preferred

An HDAC1, HDAC2, and HDAC3 inhibitor (IC50s = 63, 570, and 550 nM, respectively); increases H3K9Ac in Colon-26 cells at 2.7 µM; decreases tumor volume, reduces tumor levels of macrophages, and increases tumor levels of Cd4+ and Cd8+ T cells in a Colon-26 murine colon cancer model at 50 mg/kg per day; increases serum levels of IgG and IgM antibodies thirty days after administration in mice immunized with the SARS-CoV-2 spike glycoprotein

Catalog No. 50-298-3908 Supplier Cayman Chemical Supplier No. 21159500 UG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

An HDAC1, HDAC2, and HDAC3 inhibitor (IC50s = 63, 570, and 550 nM, respectively); increases H3K9Ac in Colon-26 cells at 2.7 µM; decreases tumor volume, reduces tumor levels of macrophages, and increases tumor levels of Cd4+ and Cd8+ T cells in a Colon-26 murine colon cancer model at 50 mg/kg per day; increases serum levels of IgG and IgM antibodies thirty days after administration in mice immunized with the SARS-CoV-2 spike glycoprotein

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.